Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this research study is to see whether adding bavituximab (an
investigational drug) to the standard chemotherapy drug docetaxel, will improve the results
of the treatment for non-small-cell lung cancer.